CRIMALDDI: platform technologies and novel anti-malarial drug targets

被引：0

作者：

Henri Vial

Donatella Taramelli

Ian C Boulton

Steve A Ward

Christian Doerig

Kelly Chibale

机构：

[1] Université Montpellier 2,Centre National de la Recherche Scientifique, UMR 5235

[2] Università di Milano,Dipartmento di Scienze Farmacologiche e Biomolecolari

[3] TropMed Pharma Consulting Ltd,Department of Microbiology

[4] Liverpool School of Tropical Medicine,Department of Chemistry

[5] School of Biomedical Sciences,undefined

[6] Monash University,undefined

[7] University of Cape Town,undefined

来源：

Malaria Journal | / 12卷

关键词：

CRIMALDDI; Malaria; Drug discovery; Research agenda; Novel targets; Enabling technologies; Prioritization;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The Coordination, Rationalization, and Integration of antiMALarial drug Discovery & Development Initiatives (CRIMALDDI) Consortium, funded by the EU Framework Seven Programme, has attempted, through a series of interactive and facilitated workshops, to develop priorities for research to expedite the discovery of new anti-malarials. This paper outlines the recommendations for the development of enabling technologies and the identification of novel targets.

引用

共 50 条

[21] Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Monatrakul, Preeyaporn
Mungthin, Mathirut
Dondorp, Arjen M.
Krudsood, Srivicha
Udomsangpetch, Rachanee
Wilairatana, Polrat
White, Nicholas J.
Chotivanich, Kesinee
MALARIA JOURNAL, 2010, 9
[22] Computational screening of molecular targets in Plasmodium for novel non resistant anti-malarial drugs
Singh, Neera
Misra, Krishna
BIOINFORMATION, 2009, 3 (06) : 255 - 262
[23] Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Preeyaporn Monatrakul
Mathirut Mungthin
Arjen M Dondorp
Srivicha Krudsood
Rachanee Udomsangpetch
Polrat Wilairatana
Nicholas J White
Kesinee Chotivanich
Malaria Journal, 9
[24] Novel pantothenate derivatives for anti-malarial chemotherapy
Helmi E Pett
Patrick AM Jansen
Pedro HH Hermkens
Peter NM Botman
Christien A Beuckens-Schortinghuis
Richard H Blaauw
Wouter Graumans
Marga van de Vegte-Bolmer
Karin MJ Koolen
Floris PJT Rutjes
Koen J Dechering
Robert W Sauerwein
Joost Schalkwijk
Malaria Journal, 14
[25] Mapping the genome of Plasmodium falciparum on the drug-like chemical space reveals novel anti-malarial targets and potential drug leads
Jensen, Kasper
Plichta, Damian
Panagiotou, Gianni
Kouskoumvekaki, Irene
MOLECULAR BIOSYSTEMS, 2012, 8 (06) : 1678 - 1685
[26] Novel pantothenate derivatives for anti-malarial chemotherapy
Pett, Helmi E.
Jansen, Patrick A. M.
Hermkens, Pedro H. H.
Botman, Peter N. M.
Beuckens-Schortinghuis, Christien A.
Blaauw, Richard H.
Graumans, Wouter
de Vegte-Bolmer, Marga van
Koolen, Karin M. J.
Rutjes, Floris P. J. T.
Dechering, Koen J.
Sauerwein, Robert W.
Schalkwijk, Joost
MALARIA JOURNAL, 2015, 14
[27] ANTI-MALARIAL ACTIVITY OF NOVEL DERIVATIVES OF PRIMAQUINE
PIRSON, P
STEIGER, RF
BAURAIN, R
MASQUELIER, M
TROUET, A
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1981, 75 (01) : 188 - 188
[28] Fragment Screening in the Development of a Novel Anti-Malarial
Du, Xiaochen
Zhang, Ran
Groves, Matthew R.
CRYSTALS, 2023, 13 (12)
[29] Does anti-malarial drug knowledge predict anti-malarial dispensing practice in drug outlets? A survey of medicine retailers in western Kenya
Andria Rusk
Nathan Smith
Diana Menya
Andrew Obala
Chrispinus Simiyu
Barasa Khwa-Otsyula
Wendy O’Meara
Malaria Journal, 11
[30] Does anti-malarial drug knowledge predict anti-malarial dispensing practice in drug outlets? A survey of medicine retailers in western Kenya
Rusk, Andria
Smith, Nathan
Menya, Diana
Obala, Andrew
Simiyu, Chrispinus
Khwa-Otsyula, Barasa
O'Meara, Wendy
MALARIA JOURNAL, 2012, 11

← 1 2 3 4 5 →